Pure Bioscience, Inc.
PURE
Revenue
1.96M
▲1.52M▲344.32%
3 Months ChangeAssets
818.00k
▼-102.00k▼-11.09%
3 Months ChangeLiabilities
3.68M
▲616.00k▲20.09%
3 Months ChangeFree Cash Flow
-939.00k
▼-309.00k▼-49.05%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001493152-24-042926
2024-09-20
Form 8-K
ID: 0001493152-24-037627
2024-08-09
Form 8-K
ID: 0001493152-24-030966
2024-06-14
Form 10-Q
ID: 0001493152-24-023869
2024-06-14
Form 8-K
ID: 0001493152-24-023859
2024-05-07
Form 8-K
ID: 0001493152-24-018114
2024-03-27
Form 8-K
ID: 0001493152-24-011536
2024-03-18
Form 10-Q
ID: 0001493152-24-010313
2024-03-18
Form 8-K
ID: 0001493152-24-010300
2024-02-26
Form 8-K
ID: 0001493152-24-007825